'Regulation By Amicus' No Longer An Option For Agencies

The article examines the U.S. Supreme Court's 5-4 ruling in favor of GlaxoSmithKline in arguing that a proposed class of its pharmaceutical sales representatives were outside sales employees exempt from the Fair Labor Standards Act's overtime pay requirements. Littler’s Tammy McCutchen provides insight on the decision as a powerful statement against federal agencies using court filings to make substantive regulatory changes.

View Article